TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
TVRD
146 hedge funds and large institutions have $563M invested in Tvardi Therapeutics, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 50 increasing their positions, 27 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
146
Holders Change
+16
Holders Change %
+12.31%
% of All Funds
3.34%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
33
Increased
50
Reduced
27
Closed
17
Calls
$20.7M
Puts
$10.6M
Net Calls
+$10.1M
Net Calls Change
+$7.92M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$46.6M |
| 2 |
BlackRock
New York
|
+$12.4M |
| 3 |
State Street
Boston,
Massachusetts
|
+$9.83M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.31M |
| 5 |
NC
Nexthera Capital
New York
|
+$7.22M |
Top Sellers
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$4.27M |
| 2 |
JPMorgan Chase & Co
New York
|
-$4.26M |
| 3 |
CG
Carmignac Gestion
Paris,
France
|
-$2.48M |
| 4 |
Parallax Volatility Advisers
San Francisco,
California
|
-$1.97M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.48M |
